TY  - GEN
AU  - Alexander,J H
AU  - Dyke,C K
AU  - Yang,H
AU  - Becker,R C
AU  - Hasselblad,V
AU  - Zillman,L A
AU  - Kleiman,N S
AU  - Hochman,J S
AU  - Berger,P B
AU  - Cohen,E A
AU  - Lincoff,A M
AU  - Saint-Jacques,H
AU  - Chetcuti,S
AU  - Burton,J R
AU  - Buergler,J M
AU  - Spence,F P
AU  - Shimoto,Y
AU  - Robertson,T L
AU  - Kunitada,S
AU  - Bovill,E G
AU  - Armstrong,P W
AU  - Harrington,R A
TI  - Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI Pilot
SN  - 1538-7933
PY  - 2004///0930
KW  - Aged
KW  - Anticoagulants
KW  - administration & dosage
KW  - Blood Coagulation Tests
KW  - Cardiac Surgical Procedures
KW  - adverse effects
KW  - Dose-Response Relationship, Drug
KW  - Drug Monitoring
KW  - methods
KW  - Factor Xa Inhibitors
KW  - Feasibility Studies
KW  - Female
KW  - Heparin
KW  - Humans
KW  - International Normalized Ratio
KW  - Intraoperative Care
KW  - Male
KW  - Middle Aged
KW  - Naphthalenes
KW  - Pilot Projects
KW  - Postoperative Complications
KW  - prevention & control
KW  - Propionates
KW  - Thrombosis
KW  - etiology
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1538-7933.2004.00594.x
ER  -